Predictors for neoplastic progression in patients with Barrett's Esophagus: a prospective cohort study. - Wikidata - wikimedia - TriplyDB

Predictors for neoplastic progression in patients with Barrett's Esophagus: a prospective cohort study.

Predictors for neoplastic progression in patients with Barrett's Esophagus: a prospective cohort study.

http://www.wikidata.org/entity/Q46115635

about

Efficacy and durability of radiofrequency ablation for Barrett's Esophagus: systematic review and meta-analysis Epidemiology of Barrett's Esophagus and Esophageal Adenocarcinoma BOB CAT: A Large-Scale Review and Delphi Consensus for Management of Barrett's Esophagus With No Dysplasia, Indefinite for, or Low-Grade Dysplasia.Endoscopic risk factors for neoplastic progression in patients with Barrett's oesophagus Barrett's oesophagus: frequency and prediction of dysplasia and cancer Barrett's esophagus and cancer risk: how research advances can impact clinical practice.Alcohol consumption and the neoplastic progression in Barrett's esophagus: a systematic review and meta-analysis.Acid-suppressive medications and risk of oesophageal adenocarcinoma in patients with Barrett's oesophagus: a systematic review and meta-analysis Improved detection of incident dysplasia by probe-based confocal laser endomicroscopy in a Barrett's esophagus surveillance program.Barrett's oesophagus: epidemiology, cancer risk and implications for management.British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus.The role of tobacco, alcohol, and obesity in neoplastic progression to esophageal adenocarcinoma: a prospective study of Barrett's esophagus Photodynamic therapy vs radiofrequency ablation for Barrett's dysplasia: efficacy, safety and cost-comparison.Mechanisms of Barrett's oesophagus (clinical): LOS dysfunction, hiatal hernia, peristaltic defects.Surveillance in Barrett esophagus Risk factors affecting the Barrett's metaplasia-dysplasia-neoplasia sequence.Predictors of Progression to High-Grade Dysplasia or Adenocarcinoma in Barrett's Esophagus.Effects of acotiamide on esophageal motor function and gastroesophageal reflux in healthy volunteers Expression of p53 predicts risk of prevalent and incident advanced neoplasia in patients with Barrett's esophagus and epithelial changes indefinite for dysplasia.The cost effectiveness of radiofrequency ablation for Barrett's esophagus.Rates and predictors of progression to esophageal carcinoma in a large population-based Barrett's esophagus cohort.Magnitude of Missed Esophageal Adenocarcinoma After Barrett's Esophagus Diagnosis: A Systematic Review and Meta-analysis Low risk of adenocarcinoma and high-grade dysplasia in patients with non-dysplastic Barrett's esophagus: Results from a cohort from a country with low esophageal adenocarcinoma incidence.Imaging heterogeneity in the mitochondrial redox state of premalignant pancreas in the pancreas-specific PTEN-null transgenic mouse model The Prevalence of Barrett Esophagus Diagnosed in the Second Endoscopy: A Retrospective, Observational Study at a Tertiary Center.Value of cyclin A immunohistochemistry for cancer risk stratification in Barrett esophagus surveillance: A multicenter case-control study Risk stratification for malignant progression in Barrett's esophagus: Gender, age, duration and year of surveillance Barrett esophagus: when to endoscope.Managing Barrett's esophagus with radiofrequency ablation Role of chemoprophylaxis with either NSAIDs or statins in patients with Barrett's esophagus.The risk of oesophageal adenocarcinoma in a prospectively recruited Barrett's oesophagus cohort.Consensus statements for management of Barrett's dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process.Management strategies of Barrett's esophagus Management controversies in Barrett's oesophagus.Review on novel concepts of columnar lined esophagus.Symptoms and endoscopic features at barrett's esophagus diagnosis: implications for neoplastic progression risk.Progression of Barrett oesophagus: role of endoscopic and histological predictors.The impact of laparoscopic anti-reflux surgery in patients with Barrett's esophagus.Barrett's oesophagus patients with low-grade dysplasia can be accurately risk-stratified after histological review by an expert pathology panel.Australian clinical practice guidelines for the diagnosis and management of Barrett's esophagus and early esophageal adenocarcinoma.

P2860

Q26821767-05C8EE3B-5CBF-4BBB-A1E5-DE677CAA150C Q26825742-FF3E6508-7AD6-4798-8DED-0C0D9AC0E520 Q27332349-B2005BA4-7A47-48B0-88B8-E56D313B877B Q28079946-2B470E29-043A-410F-B233-BDF2ACAB6EE9 Q28080794-1A01953A-5965-4361-A462-88A54941834B Q33959620-B2F30AB9-86F7-4A99-BD99-5757E06EB1FF Q34315153-89FDB9EA-86AF-4B57-A72B-86F424C85FCD Q34352867-16A246FD-0C6E-4053-A4AA-5533E3546090 Q34371996-288CC8EA-0C91-4843-9DB4-37E8248624D0 Q34375216-00C62691-2C65-4F03-8729-31F5E904864D Q34380645-D22F0E88-A60C-4BC1-8309-E3EB2D51502A Q34542075-37048BCB-1B21-4C6D-9A73-10E4C371D7C5 Q35040026-6C5C414D-9D60-4E9F-A571-0F049AA5278D Q35162477-4F60B1EF-EB2B-4E8C-8F3A-1ACD7A99C822 Q35340638-1AD2B7FE-F91A-474E-8564-394EB1512367 Q35622201-35CC96C3-4155-4B71-960F-28D07C7468DD Q35666515-71D4979E-82E3-4A8A-A908-07C988D7CAA2 Q35771441-A0B4A9F5-B8F2-42F8-A1DB-1F9219B8A9E1 Q35815186-939C7DA6-2047-4554-8B1A-F1DB7B445274 Q36195501-E9C84F49-6AAE-4805-88EA-19D435BA7E8F Q37018314-69E27B20-D59D-43D8-AB0C-023940C241FE Q37033556-2CC4AC94-7220-4F25-997D-F600BCD2A603 Q37045741-0788ADFF-BDE7-408B-B82A-9A876F2EBCBB Q37180312-3CE2E2D9-4B93-466E-81A4-D525E403310D Q37206840-AC787507-117A-4AF6-8634-4F43CE486BE0 Q37468189-E8F261B2-6C7E-476E-9831-2D96A553120E Q37538933-87F36110-3E53-4C12-AF8E-54145A735EA6 Q37591976-21F8B863-338E-46D8-907D-EE960B68CDB2 Q37609156-2F720909-07FA-49F1-B0DD-3A980F530787 Q37621036-BF08F01F-F415-4EF9-A966-8F8A3CAEFCA4 Q37744623-F4B1F771-009F-4EC0-B403-2AC803B54002 Q38005810-2EC89913-7E0C-4CBB-A718-4589ACD9CDD9 Q38062526-BB67126E-E73B-477B-AB4C-2D63A413C253 Q38111974-A7E9C86B-B404-4AC0-9CB2-DEBFA330321D Q38141855-567EBF08-E3C6-4EA5-AAF5-CA20EF153649 Q38192838-FFA2BBEB-7821-46C8-BAD6-B98DF4CED6D1 Q38214785-FC1CD3CC-6A2D-41B0-9B1E-9E9959BF8DED Q38220732-C609EB87-C305-4017-9692-ABD5C47FA154 Q38230762-A3A07122-8970-4A12-8282-BAC98BA9CE40 Q38328606-3CBFE910-B046-425C-A46E-ED6C44E3EA0F

P2860

Predictors for neoplastic progression in patients with Barrett's Esophagus: a prospective cohort study.

http://www.wikidata.org/entity/Q46115635

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh-hant

name

Predictors for neoplastic prog ...... s: a prospective cohort study.

@en

Predictors for neoplastic prog ...... s: a prospective cohort study.

@nl

type

label

Predictors for neoplastic prog ...... s: a prospective cohort study.

@en

Predictors for neoplastic prog ...... s: a prospective cohort study.

@nl

altLabel

Predictors for Neoplastic Prog ...... us: A Prospective Cohort Study

@en

prefLabel

Predictors for neoplastic prog ...... s: a prospective cohort study.

@en

Predictors for neoplastic prog ...... s: a prospective cohort study.

@nl

P1433

Q46115635-95C98343-1A7D-440D-BA08-97AC4246F3AD

P1476

Q46115635-24E7BDD4-B832-476B-8DA2-BAE7855336D5

P2093

Q46115635-0FC7864F-7F20-4D5F-BCB2-50C3638B46E5

Q46115635-1872B47D-D2DE-416C-99AD-1C9AAB04DACD

Q46115635-1B2ACF3C-2881-42C9-9259-AAFC186D41A0

Q46115635-27B09ECE-E369-4D25-89F5-FC450031DD6D

Q46115635-3347F354-C1BA-43AC-A660-29693039C292

Q46115635-355E81B6-64F2-42A9-892A-2D0BA49D0615

Q46115635-39C0522F-C6F7-4FD3-9499-ABCA8953F96A

Q46115635-3AB88222-825C-40CB-81E4-E1B39D5C016D

Q46115635-3ED5371F-E491-495B-AE41-7A5D7869492C

Q46115635-3F45E42D-D443-41ED-9A7B-0DA2410E2E9E

P2860

Q46115635-086AE584-64FA-4B63-A4AB-979124C524E6

Q46115635-0CAC055C-9E58-4085-BC16-C508C53D0180

Q46115635-0F9F7234-273E-4ABA-9A2E-CBF8DCFC3B93

Q46115635-1C302883-8A95-454B-9389-F77FF32708D5

Q46115635-2BF8F2E8-BA60-4865-AD7B-1C5F9008F5A6

Q46115635-2EE69DF5-434F-4DC5-8FC8-5F84E56B9BE5

Q46115635-2EE92BCB-5A28-409F-BE73-35B041EB96E5

Q46115635-3C0E8889-5991-44BD-87C1-4B0A05DD0B30

Q46115635-427A1D61-BEF1-4072-89AB-77002928951F

Q46115635-67316D1A-7362-41C0-9AD9-276FC807C49E

P304

Q46115635-C614C5B2-52CC-4F54-BB14-B32FCF5635AE

P31

Q46115635-B962F44A-8660-4640-8678-4E5F2CB0ACFA

P356

Q46115635-52F52233-B503-40AF-8E6E-6DAC36787069

P407

Q46115635-EA0C5278-7B1B-4C77-8169-29D9AEB5165D

P433

Q46115635-2C02FE4D-3880-4423-A19C-E39BC0E4A9AB

P478

Q46115635-4FFF0EDC-2B67-4A5B-B1B4-42520537DA7D

P50

Q46115635-56E489E8-C344-482E-9443-99DF29ED7C74

P577

Q46115635-82F7E36B-FA2C-4E17-AF1A-A1F640C23D10

P698

Q46115635-4B852A8B-73E2-4C59-82D9-8E2C6E57423B

P356

P1433

The American Journal of Gastroenterology

P1476

Predictors for neoplastic prog ...... s: a prospective cohort study.

@en

P2093

A H Mulder

http://www.w3.org/2001/XMLSchema#string

A J P van Tilburg

http://www.w3.org/2001/XMLSchema#string

A J van Vuuren

http://www.w3.org/2001/XMLSchema#string

C W N Looman

http://www.w3.org/2001/XMLSchema#string

E C Klinkenberg

http://www.w3.org/2001/XMLSchema#string

E J Kuipers

http://www.w3.org/2001/XMLSchema#string

F J W ten Kate

http://www.w3.org/2001/XMLSchema#string

F Kastelein

http://www.w3.org/2001/XMLSchema#string

F ter Borg

http://www.w3.org/2001/XMLSchema#string

G A Meijer

http://www.w3.org/2001/XMLSchema#string

P2860

The Vienna classification of gastrointestinal epithelial neoplasia

Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification

Protective association of aspirin/NSAIDs and esophageal cancer: a systematic review and meta-analysis

Is there publication bias in the reporting of cancer risk in Barrett's esophagus?

Risk factors for Barrett's oesophagus and oesophageal adenocarcinoma: results from the FINBAR study

Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation.

Only patients with dysplasia progress to adenocarcinoma in Barrett's oesophagus

Length of Barrett's oesophagus: an important factor in the development of dysplasia and adenocarcinoma

Continuous treatment of Barrett's oesophagus patients with proton pump inhibitors up to 13 years: observations on regression and cancer incidence.

Relaxing the rule of ten events per variable in logistic and Cox regression.

P304

1231-1238

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/AJG.2011.153

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

106

http://www.w3.org/2001/XMLSchema#string

P50

Ewout W. Steyerberg

P577

2011-05-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21577245

http://www.w3.org/2001/XMLSchema#string